Camlin Fine Sciences Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 08 Apr 2026, 06:36 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited submitted its compliance certificate under SEBI Depositories Regulations for Q4FY26 to BSE and NSE on April 8, 2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper dematerialisation processes and regulatory compliance for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37199172

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 to stock exchanges. The certificate pertains to the quarter ended March 31, 2026, and was filed with both BSE Limited and National Stock Exchange of India Limited on April 8, 2026.

Regulatory Compliance Submission

The company submitted the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and VP Legal Rahul Sawale signed and submitted the compliance document to ensure adherence to regulatory requirements.

Parameter Details
Regulation SEBI (Depositories and Participants) Regulations, 2018 - Section 74(5)
Quarter Period March 31, 2026
Submission Date April 8, 2026
Submitted By Rahul Sawale, Company Secretary & VP Legal

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Camlin Fine Sciences Limited. The registrar issued the confirmation certificate on April 3, 2026, which was subsequently forwarded to the stock exchanges.

Certificate Confirmations

The registrar confirmed several key compliance aspects for the quarter:

  • Securities received from depository participants for dematerialisation were properly confirmed to depositories
  • All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
  • Security certificates were mutilated and cancelled after due verification by depository participants
  • Depository names were substituted in the register of members as registered owners

Company Information

Detail Information
Registered Office Floor 2 to 5, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400098
CIN L74100MH1993PLC075361
BSE Scrip Code 532834
NSE Symbol CAMLINFINE

The submission ensures Camlin Fine Sciences Limited maintains compliance with SEBI depositories regulations, confirming proper handling of securities dematerialisation processes during the quarter ended March 31, 2026.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-4.86%+2.47%-24.31%-48.86%-23.41%-27.19%

Will SEBI introduce any new compliance requirements for depositories and participants in the upcoming quarters of 2026?

How might the transition from Link Intime to MUFG Intime India impact Camlin Fine Sciences' future share transfer processes?

What operational challenges could Camlin Fine Sciences face if dematerialisation volumes increase significantly in Q1 FY2027?

Camlin Fine Sciences Publishes Postal Ballot Notice for Authorized Share Capital Increase

3 min read     Updated on 08 Apr 2026, 01:29 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited has published its postal ballot notice in newspapers and filed regulatory disclosures with stock exchanges seeking shareholder approval to increase authorized share capital from ₹21.50 crore to ₹25 crore. The e-voting process runs from April 8 to May 7, 2026, with NSDL providing remote voting facility and JHR & Associates appointed as scrutinizer.

powered bylight_fuzz_icon
37084630

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has published its postal ballot notice in newspapers and filed regulatory disclosures seeking shareholder approval to increase its authorized share capital, marking a significant corporate development for the specialty chemicals company. The company filed the newspaper publication notice with stock exchanges on April 8, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Proposed Capital Structure Changes

The company seeks to increase its authorized share capital through an ordinary resolution that requires member approval via remote e-voting. The proposed changes represent a strategic move to provide greater financial flexibility for future operations.

Parameter: Current Structure Proposed Structure
Authorized Capital: ₹21,50,00,000 ₹25,00,00,000
Number of Shares: 21,50,00,000 equity shares 25,00,00,000 equity shares
Face Value: ₹1 per share ₹1 per share
Share Type: Equity shares ranking pari passu Equity shares ranking pari passu

E-Voting Process and Timeline

The company has established a comprehensive e-voting framework to facilitate shareholder participation in the decision-making process. National Securities Depository Limited (NSDL) will provide the remote e-voting facility for all eligible members.

Voting Details: Schedule
Cut-off Date: Friday, April 3, 2026
E-voting Commencement: Wednesday, April 8, 2026 at 9:00 a.m. IST
E-voting End: Thursday, May 7, 2026 at 5:00 p.m. IST
Results Declaration: On or before Saturday, May 9, 2026 before 5:00 p.m. IST

Members whose names appear on the register of members or list of beneficial owners as on the cut-off date will be eligible to participate in the e-voting process. The postal ballot notice has been sent electronically to members whose email addresses are registered with the company or depositories.

Regulatory Compliance and Publication

The company filed the newspaper publication notice with BSE Limited and National Stock Exchange of India Limited on April 8, 2026. The notice was published in Financial Express (English) and Loksatta (Marathi) newspapers as required under regulatory provisions. Company Secretary Rahul Sawale signed the regulatory filing confirming compliance with disclosure requirements.

Scrutinizer Appointment and Governance

The Board of Directors has appointed JHR & Associates, Practicing Company Secretary, as the scrutinizer for conducting the postal ballot process. The appointment includes multiple partners to ensure continuity and proper oversight of the voting process.

Scrutinizer Details: Information
Primary Scrutinizer: Mr. J. H. Ranade, Partner (FCS No. 4317, CP No. 2520)
Alternate 1: Mr. Sohan J. Ranade, Partner (ACS No. A33416, CP No. 12520)
Alternate 2: Ms. Tejaswi Jogal, Partner (ACS No. 29608, CP No. 14839)
Firm: M/s. JHR & Associates

Strategic Rationale and Future Plans

According to the explanatory statement, the proposed increase in authorized share capital aims to facilitate future fund-raising activities through various modes. The company has outlined several potential avenues for capital mobilization that the enhanced structure would support.

The increased authorized capital would enable the company to pursue:

  • Rights issues to existing shareholders
  • Qualified Institutional Placements (QIP)
  • Preferential allotments
  • Private placements
  • Public issues of equity shares

The resolution also necessitates a consequential amendment to Clause V of the company's Memorandum of Association to reflect the new capital structure. The proposed amendment will provide the company with enhanced flexibility to meet its strategic objectives and capitalize on growth opportunities.

Documentation and Access

The postal ballot process complies with Section 110 of the Companies Act, 2013, and Rule 20 and Rule 22 of the Companies (Management and Administration) Rules, 2014. The company has also ensured adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable regulatory frameworks.

Shareholders can access the complete postal ballot notice on the company's website at www.camlins.com , as well as on the websites of BSE Limited and National Stock Exchange of India Limited. The notice includes comprehensive instructions for the e-voting process and guidelines for shareholders holding securities in both demat and physical modes.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-4.86%+2.47%-24.31%-48.86%-23.41%-27.19%

What specific growth opportunities or acquisitions is Camlin Fine Sciences targeting that would require the additional ₹3.5 crore in authorized capital?

How might the specialty chemicals market conditions influence the timing and pricing of Camlin's planned fund-raising activities?

Will the increased authorized share capital lead to dilution concerns among existing shareholders, and how might this affect the stock price?

More News on Camlin Fine Sciences

1 Year Returns:-23.41%